famotidine and cefpodoxime proxetil

famotidine has been researched along with cefpodoxime proxetil in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borner, K; Depperman, KM; Koeppe, P; Lode, H; Neider, K; Saathoff, N1
Ahmed, A; Ali, M; Furqan, H; Hassan, A; Hassan, S; Hussain, K; Iqbal, S; Nazim, U; Shereen, -; Zaheer, E1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Trials

1 trial(s) available for famotidine and cefpodoxime proxetil

ArticleYear
Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:4

    Topics: Administration, Oral; Adult; Aluminum Hydroxide; Antacids; Cefpodoxime Proxetil; Ceftizoxime; Drug Combinations; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Magnesium Hydroxide; Male; Prodrugs; Safety

1992

Other Studies

4 other study(ies) available for famotidine and cefpodoxime proxetil

ArticleYear
In vitro Spectroscopic studies on drug interaction of cefpodoxime proxetil and H2 receptor blockers.
    Pakistan journal of pharmaceutical sciences, 2019, Volume: 32, Issue:2 (Supplem

    Topics: Cefpodoxime Proxetil; Ceftizoxime; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Ranitidine; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet

2019
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013